2022-11823. Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 1, 2022. Such persons may also file a written request for a hearing on the application on or before August 1, 2022.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on December 29, 2021, Sigma Aldrich Research Biochemicals, Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    Cathinone1235I
    4-Methyl-N-Methylcathinone1248I
    Methaqualone2565I
    JWH-018 & AM6787118I
    1-(5-Fluoropentyl)-3-(1-Naphthoyl)Indole7201I
    Lysergic Acid Diethylamide7315I
    Tetrahydrocannabinols7370I
    Mescaline7381I
    2,5-Dimethoxyamphetamine7396I
    3,4-Methylenedioxymethamphetamine7405I
    Alpha-Methyltryptamine7432I
    Dimethyltryptamine7435I
    5-Methoxy-N,N-Diisopropyltryptamine7439I
    1-Benzylpiperazine7493I
    2-(2,5-Dimethoxyphenyl)Ethanamine7517I
    3,4-Methylenedioxypyrovalerone7535I
    3,4-Methylenedioxy-N-Methylcathinone7540I
    Heroin9200I
    Normorphine9313I
    Norlevorphanol9634I
    Acetyl Fentanyl9821I
    Amphetamine1100II
    Start Printed Page 33515
    Methylphenidate1724II
    Nabilone7379II
    Phencyclidine7471II
    Cocaine9041II
    Codeine9050II
    Ecgonine9180II
    Levorphanol9220II
    Meperidine9230II
    Methadone9250II
    Morphine9300II
    Thebaine9333II
    Levo-Alphacetylmethadol (LAAM)9648II
    Noroxymorphone9668II
    Remifentanil9739II
    Sufentanil9740II
    Carfentanil9743II
    Fentanyl9801II

    The company plans to manufacture reference standards.

    Start Signature

    Kristi O'Malley,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2022-11823 Filed 6-1-22; 8:45 am]

    BILLING CODE P

Document Information

Published:
06/02/2022
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2022-11823
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 1, 2022. Such persons may also file a written request for a hearing on the application on or before August 1, 2022.
Pages:
33514-33515 (2 pages)
Docket Numbers:
Docket No. DEA-954
PDF File:
2022-11823.pdf
Supporting Documents:
» Bulk Manufacturer Application - Sigma Aldrich (2022-11823) - DEA954